Literature DB >> 3079671

Correlation of placental microsomal activities with protein detected by antibodies to rabbit cytochrome P-450 isozyme 6 in preparations from humans exposed to polychlorinated biphenyls, quaterphenyls, and dibenzofurans.

T K Wong, B A Domin, P E Bent, T E Blanton, M W Anderson, R M Philpot.   

Abstract

Placental tissues were obtained from Chinese women in Taiwan who had been exposed to contaminated rice oils containing polychlorinated biphenyls and their thermal degradative products. Exposure via the diet occurred 4-5 years prior to pregnancy. Placental microsomal fractions from eight of the nine exposed subjects studied showed marked elevation of benzo(a)pyrene hydroxylation and 7-ethoxyresorufin O-deethylation activities related to control subjects. Placental microsomes from exposed subjects were found to contain a protein that cross-reacted with antibodies raised to rabbit cytochrome P-450 isozyme 6, an isozyme induced by polycyclic aromatic hydrocarbons. This protein was not observed with microsomal samples from control subjects. A significant correlation was found between the relative amounts of the immunoreactive protein and benzo(a)-pyrene hydroxylation and 7-ethoxyresorufin O-deethylation activities. The 7-ethoxyresorufin O-deethylation activities were inhibited by alpha-naphthoflavone, a compound known to inhibit activities of rabbit cytochrome P-450, isozyme 6.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3079671

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

Review 1.  Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

Authors:  M Pirmohamed; S Madden; B K Park
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

2.  A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking.

Authors:  D Sesardic; A R Boobis; R J Edwards; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

3.  The use of computers in the safety evaluation of drugs and other chemicals.

Authors:  C Ioannides; D F Lewis; D V Parke
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jul-Sep       Impact factor: 2.441

4.  Induction of hepatic CYP1A activity as a biomarker for environmental exposure to Aroclor 1254 in feral rodents.

Authors:  R A Lubet; R W Nims; L E Beebe; S D Fox; H J Issaq; K McBee
Journal:  Arch Environ Contam Toxicol       Date:  1992-04       Impact factor: 2.804

5.  The induction of alkoxyresorufin metabolism: a potential indicator of environmental contamination.

Authors:  R A Lubet; F P Guengerich; R W Nims
Journal:  Arch Environ Contam Toxicol       Date:  1990 Mar-Apr       Impact factor: 2.804

6.  Monoclonal antibodies against human cytochrome P-450 recognizing different pregnenolone 16 alpha-carbonitrile-inducible rat cytochromes P-450.

Authors:  T S Barnes; P M Shaw; M D Burke; W T Melvin
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

7.  Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

Authors:  D Sesardic; A R Boobis; B P Murray; S Murray; J Segura; R de la Torre; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

Review 8.  Animal models of human response to dioxins.

Authors:  J A Grassman; S A Masten; N J Walker; G W Lucier
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

9.  Reduced birthweight and length in the offspring of females exposed to PCDFs, PCP, and lindane.

Authors:  W Karmaus; N Wolf
Journal:  Environ Health Perspect       Date:  1995-12       Impact factor: 9.031

10.  Placental markers of human exposure to polychlorinated biphenyls and polychlorinated dibenzofurans.

Authors:  G W Lucier; K G Nelson; R B Everson; T K Wong; R M Philpot; T Tiernan; M Taylor; G I Sunahara
Journal:  Environ Health Perspect       Date:  1987-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.